Computational analyses for cancer biology based on exhaustive experimental backgrounds

Antitumor drug therapy plays a very important role in cancer treatment. However, resistance to chemotherapy is a serious issue. Many studies have been conducted to understand and verify the cause of chemoresistance from multiple points of view such as oncogenes, tumor suppressor genes, DNA mutations and repairs, autophagy, cancer stemness, and mitochondrial metabolism and alteration. Nowadays, not only medical data from hospitals but also public big data exist on internet websites. Consequently, the importance of computational science has vastly increased in biological and medical sciences. Using statistical or mathematical analyses of these medical data with conventional experiments, many researchers have recently shown that there is a strong relationship between the biological metabolism and chemoresistance for cancer therapy. For example, folate metabolism that mediates onecarbon metabolism and polyamine metabolism have garnered attention regarding their association with cancer. It has been suggested that these metabolisms may be involved in causing resistance to chemotherapy.

[1]  P. Schumacker,et al.  Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? , 2014, Nature Reviews Cancer.

[2]  R. Deberardinis,et al.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.

[3]  R. Reddel,et al.  Alternative lengthening of telomeres: models, mechanisms and implications , 2010, Nature Reviews Genetics.

[4]  David Lane,et al.  p53 Research: the past thirty years and the next thirty years. , 2010, Cold Spring Harbor perspectives in biology.

[5]  S. Weinhouse,et al.  The Warburg hypothesis fifty years later , 2004, Zeitschrift für Krebsforschung und Klinische Onkologie.

[6]  J. Little,et al.  Folate, DNA stability and colo-rectal neoplasia , 2004, Proceedings of the Nutrition Society.

[7]  J. Dick,et al.  Stem cell concepts renew cancer research. , 2008, Blood.

[8]  S. Vokes,et al.  Deletion of Mthfd1l causes embryonic lethality and neural tube and craniofacial defects in mice , 2012, Proceedings of the National Academy of Sciences.

[9]  Stephen L. Abrams,et al.  Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. , 2007, Biochimica et biophysica acta.

[10]  H. Ishii,et al.  Depletion of JARID1B induces cellular senescence in human colorectal cancer. , 2013, International journal of oncology.

[11]  M. Blasco Telomeres and human disease: ageing, cancer and beyond , 2005, Nature Reviews Genetics.

[12]  H. Matsui,et al.  Mathematical analysis predicts imbalanced IDH1/2 expression associates with 2-HG-inactivating β-oxygenation pathway in colorectal cancer. , 2015, International journal of oncology.

[13]  K. Schulze-Osthoff,et al.  Cancer stem cell markers in common cancers - therapeutic implications. , 2008, Trends in molecular medicine.

[14]  Hua-Chuan Zheng The molecular mechanisms of chemoresistance in cancers , 2017, Oncotarget.

[15]  D. Bar-Sagi,et al.  RAS oncogenes: weaving a tumorigenic web , 2011, Nature Reviews Cancer.

[16]  Anthony Mancuso,et al.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.

[17]  H. Ishii,et al.  Identification of chemoradiation-resistant osteosarcoma stem cells using an imaging system for proteasome activity. , 2014, International journal of oncology.

[18]  Eric S. Lander,et al.  Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.

[19]  H. Matsui,et al.  Computational trans-omics approach characterised methylomic and transcriptomic involvements and identified novel therapeutic targets for chemoresistance in gastrointestinal cancer stem cells , 2018, Scientific Reports.

[20]  K. Macleod The RB tumor suppressor: a gatekeeper to hormone independence in prostate cancer? , 2010, The Journal of clinical investigation.

[21]  S. Ravanel,et al.  One-Carbon Metabolism in Plants. Regulation of Tetrahydrofolate Synthesis during Germination and Seedling Development , 2003, Plant Physiology.

[22]  R. Deberardinis,et al.  Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.

[23]  J. Shay,et al.  Hayflick, his limit, and cellular ageing , 2000, Nature Reviews Molecular Cell Biology.

[24]  John L Cleveland,et al.  Myc pathways provoking cell suicide and cancer , 2003, Oncogene.

[25]  A. Chou,et al.  Immunohistochemistry for Myc Predicts Survival in Colorectal Cancer , 2014, PloS one.

[26]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[27]  P. M. Campbell,et al.  Oncogenic Ras and its role in tumor cell invasion and metastasis. , 2004, Seminars in cancer biology.

[28]  H. Matsui,et al.  A Trans-omics Mathematical Analysis Reveals Novel Functions of the Ornithine Metabolic Pathway in Cancer Stem Cells , 2016, Scientific Reports.

[29]  D. Sabatini,et al.  Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.

[30]  W. R. Bruce,et al.  A Quantitative Assay for the Number of Murine Lymphoma Cells capable of Proliferation in vivo , 1963, Nature.

[31]  L. Jaenicke VITAMIN AND COENZYME FUNCTION: VITAMIN B 12 AND FOLIC ACID. , 1964, Annual review of biochemistry.

[32]  G. Qing,et al.  Targeting oncogenic Myc as a strategy for cancer treatment , 2018, Signal Transduction and Targeted Therapy.

[33]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[34]  H. Ishii,et al.  Polyamine flux suppresses histone lysine demethylases and enhances ID1 expression in cancer stem cells , 2018, Cell Death Discovery.

[35]  P. Leedman,et al.  Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. , 2002, The Biochemical journal.

[36]  A. Lusis,et al.  Considerations for the design of omics studies , 2017 .

[37]  Ita Novita Sari,et al.  Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment , 2018, Stem cells international.

[38]  David A. Williams,et al.  Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy , 1996, Nature Medicine.

[39]  Akane Kawamura,et al.  Recent Progress in Histone Demethylase Inhibitors. , 2016, Journal of medicinal chemistry.

[40]  H. Kim,et al.  Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking In Vitro Models in Anti-Cancer Drug Development , 2018, Theranostics.

[41]  H. Lodish,et al.  Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. , 1987, Science.

[42]  D. Root,et al.  Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival. , 2018, Cancer discovery.

[43]  H. Ishii,et al.  Visualization and characterization of cancer stem-like cells in cervical cancer. , 2014, International journal of oncology.

[44]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[45]  P. Stover,et al.  Trafficking of intracellular folates. , 2011, Advances in nutrition.

[46]  Robert A. Weinberg,et al.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.

[47]  H. Ishii,et al.  Drug discovery of anticancer drugs targeting methylenetetrahydrofolate dehydrogenase 2 , 2018, Heliyon.

[48]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[49]  O. Warburg [Origin of cancer cells]. , 1956, Oncologia.

[50]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[51]  Gang Li,et al.  Cancer chemoresistance: The relationship between p53 and multidrug transporters , 2002, International journal of cancer.

[52]  E. Adams Amino acid metabolism. , 1962, Annual review of biochemistry.

[53]  Hiroyuki Kubota,et al.  Trans-Omics: How To Reconstruct Biochemical Networks Across Multiple 'Omic' Layers. , 2016, Trends in biotechnology.

[54]  Z. Hall Cancer , 1906, The Hospital.

[55]  A. Inga,et al.  More targets, more pathways and more clues for mutant p53 , 2013, Oncogenesis.

[56]  T. Oberley Oxidative damage and cancer. , 2002, The American journal of pathology.

[57]  R. Weinberg,et al.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.

[58]  Giovanni Parmigiani,et al.  Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation , 2013, Proceedings of the National Academy of Sciences.

[59]  R. Mackenzie,et al.  Mitochondrial one-carbon metabolism is adapted to the specific needs of yeast, plants and mammals. , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.

[60]  Jean C. Y. Wang Good cells gone bad: the cellular origins of cancer. , 2010, Trends in molecular medicine.

[61]  Julien Verrax,et al.  Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.

[62]  Igor Jurisica,et al.  Cancer computational biology , 2011, BMC Bioinformatics.

[63]  Lewis C Cantley,et al.  The phosphoinositide 3-kinase pathway. , 2002, Science.

[64]  E. Racker Why do tumor cells have a high aerobic glycolysis? , 1976, Journal of cellular physiology.

[65]  Niko Beerenwinkel,et al.  Computational Cancer Biology: An Evolutionary Perspective , 2016, PLoS Comput. Biol..

[66]  E. Asselin,et al.  Chemoresistance and targeted therapies in ovarian and endometrial cancers , 2016, Oncotarget.

[67]  A. Fernández-Medarde,et al.  Ras in cancer and developmental diseases. , 2011, Genes & cancer.

[68]  M. Birnbaum,et al.  Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. , 1987, Science.

[69]  S. Inoue,et al.  Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. , 2015, Cancer cell.

[70]  H. Ishii,et al.  Jumonji/Arid1b (Jarid1b) protein modulates human esophageal cancer cell growth , 2013, Molecular and clinical oncology.

[71]  B. Vogelstein,et al.  Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, Science.

[72]  C. Ryu,et al.  Cancer stem cell surface markers on normal stem cells , 2017, BMB reports.

[73]  R. Kuick,et al.  Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer , 2016, Cell.

[74]  L. Reitzer,et al.  Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. , 1979, The Journal of biological chemistry.

[75]  J. Sayre,et al.  In vivo imaging, tracking, and targeting of cancer stem cells. , 2009, Journal of the National Cancer Institute.

[76]  Varda Rotter,et al.  Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis. , 2011, Genes & cancer.

[77]  Serban Nacu,et al.  A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. , 2010, Cancer cell.

[78]  H. Shimizu,et al.  Metabolic Adaptation to Nutritional Stress in Human Colorectal Cancer , 2016, Scientific Reports.

[79]  J. Shay,et al.  Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies , 2016, Genome Medicine.

[80]  David E. Muench,et al.  c-Myc and Cancer Metabolism , 2012, Clinical Cancer Research.

[81]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[82]  T. Ochiya,et al.  Drug Resistance Driven by Cancer Stem Cells and Their Niche , 2017, International journal of molecular sciences.

[83]  I. Weissman,et al.  Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.

[84]  A. Levine,et al.  The first 30 years of p53: growing ever more complex , 2009, Nature Reviews Cancer.

[85]  B. Vogelstein,et al.  Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention , 2017, Science.